The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 24, 2016

Filed:

Apr. 04, 2011
Applicants:

Renata Castiglioni Pascon, Campinas, BR;

Ana Claudia Rasera Silva, Campinas, BR;

Inventors:
Assignee:

MONSANTO DO BRASIL LTDA., Sao Paulo, BR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01H 5/00 (2006.01); C07K 14/005 (2006.01); C12Q 1/70 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); C12Q 1/701 (2013.01); C12N 2760/20022 (2013.01);
Abstract

The present disclosure embraces nucleic acid molecules found in the genome of theLeprosis Virus (CiLV), which is associated toLeprosis (CiL) disease. The cloned CiLV nucleic acid molecules can be used as probes or can be used to design oligonucleotide primers for detecting CiLV in biological samples, particularly leaves, roots and other tissues or organs of plants, such as plants from the generaand. The cloned CiLV nucleic acid molecules are expressed in cells to provide immunogenic proteins for raising antibodies against CiLV, which can then be used to detect CiLV in biological samples. It also comprises the nucleic acid molecules represented in SEQ ID Nos. 5 and 8, in whole or part, as well as transgenic plants, such as monocots and dicots, containing the CiLV nucleic acid molecules, in any kind of combination, so that expression increases resistance to CiL disease.


Find Patent Forward Citations

Loading…